β-Amyloid peptides display protective activity against the human Alzheimer’s disease-associated herpes simplex virus-1

Akhtar J, Shukla D (2009) Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J 276:7228–7236

Bekris LM, Yu CE, Bird TD, Tsuang DW (2010) Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol 23:213–227

Benilova I, Karran E, De Strooper B (2012) The toxic Aβ oligomer and Alzheimer’s disease: an emperor in need of clothes. Nat Neurosci 15:349–357

Bowdish DM, Davidson DJ, Lau YE, Lee K, Scott MG, Hancock RE (2005) Impact of LL-37 on anti-infective immunity. J Leukoc Biol 77:451–459

Burton MF, Steel PG (2009) The chemistry and biology of LL-37. Nat Prod Rep 26:1572–1584

Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622

Carty M, Reinert L, Paludan SR, Bowie AG (2014) Innate antiviral signalling in the central nervous system. Trends Immunol 35:79–87

Castellani RJ, Rolston RK, Smith MA (2010) Alzheimer disease. Disease-a-Month 56:484–546

Cribbs DH, Azizeh BY, Cotman CW, LaFerla FM (2000) Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer’s A beta peptide. Biochemistry 39:5988–5994

Cupelli K, Stehle T (2011) Viral attachment strategies: the many faces of adenoviruses. Curr Opin Virol 1:84–91

De Chiara G, Marcocci ME, Civitelli L, Argnani R, Piacentini R, Ripoli C, Manservigi R, Grassi C, Garaci E, Palamara AT (2010) APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. PLoS ONE 5:e13989

Denaro FJ, Staub P, Colmer J, Freed DM (2003) Coexistence of Alzheimer disease neuropathology with herpes simplex encephalitis. Cell Mol Biol 49:1233–1240

Egan KP, Wu S, Wigdahl B, Jennings SR (2013) Immunological control of herpes simplex virus infections. J Neurovirol 19:328–345

Eisenberg RJ, Atanasiu D, Cairns TM, Gallagher JR, Krummenacher C, Cohen GH (2012) Herpes virus fusion and entry: a story with many characters. Viruses 4:800–832

Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69(Suppl 1):S4–S9

Frasca L, Lande R (2012) Role of defensins and cathelicidin LL37 in auto-immune and auto-inflammatory diseases. Curr Pharm Biotechnol 13:1882–1897

Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, Hooli B, Choi SH, Hyman BT, Tanzi RE (2013) Alzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78:631–643

Grünewald K, Desai P, Winkler DC, Heymann JB, Belnap DM, Baumeister W, Steven AC (2003) Three-dimensional structure of herpes simplex virus from cryo-electron tomography. Science 302:1396–1398

Halverson K, Fraser PE, Kirschner DA, Lansbury PT (1990) Molecular determinants of amyloid deposition in Alzheimer’s disease: conformational studies of synthetic beta-protein fragments. Biochemistry 29:2639–2644

Heldwein KE, Lou H, Bender FC, Cohen GH, Eisenberg RJ, Harrison SC (2006) Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313:217–220

Itzhaki RF, Wozniak MA (2012) Could antivirals be used to treat Alzheimer’s disease? Future Microbiol 7:307–309

Jang H, Arce FT, Ramachandran S, Capone R, Azimova R, Kagan BL, Nussinov R, Lal R (2010) Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer’s disease and Down syndrome. Proc Natl Acad Sci USA 107:6538–6543

Jang H, Connelly L, Arce FT, Ramachandran S, Kagan BL, Lal R, Nussinov R (2013) Mechanisms for the insertion of toxic, fibril-like β-amyloid oligomers into the membrane. J Chem Theory Comput 9:822–833

Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10:698–712

Larbi A, Pawelec G, Witkowski JM, Schipper HM, Derhovanessian E, Goldeck D, Fulop T (2009) Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer’s disease. J Alzheimers Dis 17(1):91–103

Letenneur L, Peres K, Fleury H, Garrigue I, Barberger-Gateau P, Helmer C, Orgogozo JM, Gauthier S, Dartigues JF (2008) Seropositivity to herpes simplex virus antibodies and risk of Alzheimer’s disease: a population-based cohort study. PLoS ONE 3:e3637

Lin WR, Wozniak MA, Cooper RJ, Wilcock GK, Itzhaki RF (2002) Herpesviruses in brain and Alzheimer’s disease. J Pathol 197:395–402

Masters CL, Selkoe DJ (2012) Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harb Perspect Med 2:a006262

Miklossy J (2011) Emerging roles of pathogens in Alzheimer disease. Expert Rev Mol Med 13:e30

Nemerow GR, Stewart PL, Reddy VS (2012) Structure of human adenovirus. Curr Opin Virol 2:115–121

Nicoll MP, Proença JT, Efstathiou S (2012) The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev 36:684–705

Pearson HA, Peers C (2006) Physiological roles for amyloid beta peptides. J Physiol 575:5–10

Perneczky R, Guo LH, Kagerbauer SM, Werle L, Kurz A, Martin J, Alexopoulos P (2013) Soluble amyloid precursor protein beta as blood-based biomarker of Alzheimer’s disease. Transl Psychiatry 3:e227

Piacentini R, Civitelli L, Ripoli C, Marcocci ME, De Chiara G, Garaci E, Azzena GB, Palamara AT, Grassi C (2011) HSV-1 promotes Ca2+-mediated phosphorylation and Aβ accumulation in rat cortical neurons. Neurobiol Aging 32(2323):e13–e26

Piacentini R, De Chiara G, Li Puma DD, Ripoli C, Marcocci ME, Garaci E, Palamara AT, Grassi C (2014) HSV-1 and Alzheimer’s disease: more than a hypothesis. Front Pharmacol 5:97

Querfurth HW, LaFerla FM (2010) Alzheimer’s disease. N Engl J Med 362:329–344

Reske A, Pollara G, Krummenacher C, Chain BM, Katz DR (2007) Understanding HSV-1 entry glycoproteins. Rev Med Virol 17:205–215

Rigamonti A, Lauria G, Mantero V, Salmaggi A (2013) A case of late herpes simplex encephalitis relapse. J Clin Virol 58:269–270

Russell WC (2009) Adenoviruses: update on structure and function. J Gen Virol 90:1–20

Sciacca MF, Kotler SA, Brender JR, Chen J, Lee DK, Ramamoorthy A (2012) Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation. Biophys J 103:702–710

Seeman P, Seeman N (2011) Alzheimer’s disease β-amyloid plaque formation in human brain. Synapse 65:1289–1297

Smith JG, Wiethoff CM, Stewart PL, Nemerow GR (2010) Adenovirus. Curr Top Microbiol Immunol 343:195–224

Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD (2010) The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS ONE 5:e9505

Streit WJ, Xue QS (2014) Human CNS immune senescence and neurodegeneration. Curr Opin Immunol 29C:93–96

Sun E, He J, Zhuang X (2013) Live cell imaging of viral entry. Curr Opin Virol 3:34–43

Tam JH, Pasternak SH (2012) Amyloid and Alzheimer’s disease: inside and out. Can J Neurol Sci 39:286–298

Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI (1998) Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 42:2206–2214

White MR, Kandel R, Tripathi S, Condon D, Taubenberger J, Hartshorn KL (2014) Alzheimer’s associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS ONE 9:e101364

WHO report (2013) Dementia: a public health priority. 11 Apr 2013

Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB (2007) Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett 429:95–100

Wozniak MA, Mee AP, Itzhaki RF (2009) Herpes simplex virus type 1 DNA is located within Alzheimer’s disease amyloid plaques. J Pathol 217:131–138

Wozniak MA, Frost AL, Preston CM, Itzhaki RF (2011) Antivirals reduce the formation of key Alzheimer’s disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS ONE 6:e25152

Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease. Science 245:417–420

Zhao LN, Long H, Mu Y, Chew LY (2012) The toxicity of amyloid β oligomers. Int J Mol Sci 13:7303–7307